Anbin Huang

484 total citations
11 papers, 180 citations indexed

About

Anbin Huang is a scholar working on Rheumatology, Immunology and Infectious Diseases. According to data from OpenAlex, Anbin Huang has authored 11 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Anbin Huang's work include Eosinophilic Disorders and Syndromes (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). Anbin Huang is often cited by papers focused on Eosinophilic Disorders and Syndromes (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). Anbin Huang collaborates with scholars based in China and United States. Anbin Huang's co-authors include Li Dong, Chunde Bao, Dongbao Zhao, Cong Ye, Xiang-Pei Li, Wenyu Zhou, Xiaoqiang Hou, Zhanguo Li, Xinfang Huang and Ping Zhu and has published in prestigious journals such as The Lancet, Lupus and Clinical Rheumatology.

In The Last Decade

Anbin Huang

10 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anbin Huang China 6 66 64 55 43 30 11 180
Fadi Kharouf Canada 5 72 1.1× 27 0.4× 8 0.1× 28 0.7× 30 1.0× 35 142
Essack Mitha United States 7 31 0.5× 65 1.0× 51 0.9× 38 0.9× 2 0.1× 13 229
Marta Melgosa Spain 10 60 0.9× 21 0.3× 98 1.8× 27 0.6× 6 0.2× 14 256
Camelia Badea Romania 8 66 1.0× 99 1.5× 5 0.1× 20 0.5× 28 0.9× 26 243
Hamza Sakhi France 7 65 1.0× 32 0.5× 42 0.8× 12 0.3× 11 0.4× 16 151
Michelle Mueller United States 5 39 0.6× 84 1.3× 130 2.4× 36 0.8× 9 0.3× 9 268
Charlotte Colosio France 9 42 0.6× 8 0.1× 51 0.9× 49 1.1× 10 0.3× 18 254
Gloria Pérez‐Rus Spain 7 80 1.2× 26 0.4× 7 0.1× 14 0.3× 37 1.2× 14 214
Koyal Jain United States 7 20 0.3× 37 0.6× 44 0.8× 16 0.4× 3 0.1× 23 177
Ahmet Burak Dirim Türkiye 10 82 1.2× 8 0.1× 76 1.4× 31 0.7× 42 1.4× 45 212

Countries citing papers authored by Anbin Huang

Since Specialization
Citations

This map shows the geographic impact of Anbin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anbin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anbin Huang more than expected).

Fields of papers citing papers by Anbin Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anbin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anbin Huang. The network helps show where Anbin Huang may publish in the future.

Co-authorship network of co-authors of Anbin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Anbin Huang. A scholar is included among the top collaborators of Anbin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anbin Huang. Anbin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Huang, Anbin, et al.. (2024). Pharmacological Strategies in Dermatomyositis: Current Treatments and Future Directions. Medical Science Monitor. 30. e944564–e944564. 1 indexed citations
2.
Yu, Qi, et al.. (2023). Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model. Medical Science Monitor. 29. e940251–e940251. 3 indexed citations
3.
Zhong, Jixin, Guifen Shen, Huiqin Yang, et al.. (2020). COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. The Lancet Rheumatology. 2(9). e557–e564. 79 indexed citations
4.
Zhao, Lin, et al.. (2020). Severe pneumonia in Chinese patients with systemic lupus erythematosus. Lupus. 29(7). 735–742. 9 indexed citations
6.
Chen, Xiaoxiang, Zhanguo Li, Huaxiang Wu, et al.. (2016). A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate. Clinical Rheumatology. 35(9). 2175–2183. 8 indexed citations
7.
Huang, Xinfang, Hui Du, Jieruo Gu, et al.. (2014). An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. International Journal of Rheumatic Diseases. 17(6). 679–686. 56 indexed citations
9.
Yu, Likai, et al.. (2011). Relatively increased number of liver Foxp3+ regulatory T cells against hepatic lesions in murine lupus. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(4). 476–481. 4 indexed citations
10.
Huang, Anbin, et al.. (2005). Safety Monitoring of the Yellow River Dike Using an Optic Fiber Sensor System. 103–110. 1 indexed citations
11.
Huang, Anbin, et al.. (2003). Effect of technetium-99 conjugated with methylene diphosphonate on IgM-RF, IgG-RF and IgA-RF. Current Medical Science. 23(3). 266–268. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026